EN
HI
Lupin share price chart
Lupin Share Key Metrics
Volume
5.85 L
Market Cap
109717.52 CR
LTQ@LTP
1@2399.60
ATP
2395.24
Var Margin
12.55 %
Circuit Range
2157.8-2637.2
Delivery %
54.9 %
Value
140.04 CR
ASM/GSM
No
Market Lot
1
Summary
LUPIN stock price is ₹2399.6 as of 2 Jul, 2026. The stock intraday movement has stayed between ₹2382.70 and ₹2423.80, while Lupin share price 52 week high low is ₹1836.80 & ₹2494.00.
In terms of trading activity, LUPIN share price has recorded a volume of 5,84,679 shares. The Lupin has a market cap of ₹457232536. The stock’s Average Traded Price (ATP) stands at ₹2395.24, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹2399.60.
The Lupin upper circuit limit is ₹2637.20 & The Lupin lower circuit limit is ₹2157.80, with a Value of ₹140.04 CR. The Delivery Percentage for the day is 54.9%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Lupin Fundamentals
P/E Ratio
20.55
P/B Ratio
4.88
Div. Yield
0.75
Sector P/E
70.39
Sector P/B
3.14
Sec. Div. Yield
0.53
Lupin Resistance and Support
Pivot 2410.97
Resistance
First Resistance
2429.94
Second Resistance
2462.37
Third Resistance
2481.34
Support
First Support
2378.54
Second Support
2359.57
Third Support
2327.14
Lupin Futures & Options
Lupin Option Chain
View Price, OI, Greeks & More...
28JUL26
2392.70
5.10 (0.21%)
25AUG26
2405.00
10.40 (0.43%)
29SEP26
2416.20
8.50 (0.35%)
LUPIN|28JUL26 CE 2380.00
60.30
1.4 (2.38%)
LUPIN|28JUL26 PE 2400.00
53.3
-6.65 (-11.09%)
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
Lupin News
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin received an Establishment Inspection Report (EIR) from the U.S. FDA for its Somerset manufacturing facility, with a satisfactory Voluntary Action Indicated (VAI) classification. This outcome reflects the company's commitment to quality and compliance, which is crucial for its operations.
Jul 01 2026 21:55:38
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin received EMA approval for NaMuscla® to expand its pediatric indication to treat non-dystrophic myotonic disorders in children and adolescents. This approval also includes new 62mg and 83mg dosage strengths, in addition to the existing 167mg.
Jul 01 2026 16:47:31
Read More
Lupin Management
| Name | Position |
|---|---|
| Manju D Gupta | Chairperson |
| Nilesh Gupta | Managing Director |
Lupin Similar Stocks
Apollo Hospitals Enterprise Ltd.
8696.00
77.50 (0.90%)
Cipla Ltd.
1456.00
-0.70 (0.05%)
Dr. Reddy's Laboratories Ltd.
1345.70
5.80 (0.43%)
Zydus Lifesciences Ltd.
1099.80
-9.40 (0.85%)
Max Healthcare Institute Ltd.
1127.40
-12.50 (1.10%)
Mankind Pharma Ltd.
2486.90
-3.40 (0.14%)
Aurobindo Pharma Ltd.
1561.00
8.40 (0.54%)
Lenskart Solutions Ltd.
530.40
-0.15 (0.03%)
Lupin FAQs
The Buying Price of Lupin share is 2399.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lupin stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lupin, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lupin shares is 20.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lupin shares is 4.88. Useful to assess the stock's value relative to its book value.
To assess Lupin’s valuation compare Sector P/E, P/B which are 70.39 & 3.14 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lupin is 109717.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lupin share price is 2494.00 & 1836.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lupin belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
